Showing 5271-5280 of 6964 results for "".
- Nancy Beesley Joins Dermavant Board of Directorshttps://practicaldermatology.com/news/nancy-beesley-joins-dermavant-board-of-directors/2461101/Nancy Beesley has been appointed to Dermavant Sciences’ Board of Directors. She joins Dermavant with more than 25 years of experience in commercializing and branding therapeutics for the treatment of various dermatological, ophthalmic, and neurologica
- Aquaphor Unveils New Purpose-Driven Brand Campaignhttps://practicaldermatology.com/news/aquaphor-unveils-new-purpose-driven-brand-campaign/2461099/Aquaphor is launching its first-ever brand purpose campaign, "Before & Aquaphor." Inspired by the growing field of psychodermatology, this new integrated campaign highlights the connection between our skin health and our emotional well-being.
- Study: Melanoma Referral Centers Worldwide Adopt Systemic Therapies, Reduce Lymph Node Removal Surgerieshttps://practicaldermatology.com/news/study-melanoma-referral-centers-worldwide-adopt-systemic-therapies-reduce-lymph-node-removal-surgeries/2461097/Lymph node removal surgery for patients with high-risk melanoma has become less common over the past few years while the use of targeted and immune therapies has risen rapidly at melanoma referral centers worldwide, an international group of researchers found. However, a large degree of
- Butt First, Endo Launches New Qwo Consumer Campaignhttps://practicaldermatology.com/news/butt-first-endo-launches-new-qwo-consumer-campaign/2461095/Endo International plc is kicking off more than 200 patient events across the United States as part of Butt First, a new direct-to-consumer awareness campaign about Qwo (collagenase clostridium histolyticum-aaes). Qwo received FDA approval in Jul
- Mblue Labs Introduces First Anti-Aging, Coral Safe Sunscreen with Methylene Bluehttps://practicaldermatology.com/news/mblue-labs-introduces-first-anti-aging-coral-safe-sunscreen-with-methylene-blue/2461094/Mblue Labs is launching Bluevado SunFix, the first sunscreen with Methylene Blue, a centuryold medicine that is also safe for coral reefs and also delays skin aging. Fully 80 percent of today’s sunscreens use Oxybenzone as a chemical UV blocker, despite studies that have show
- Meet the Winners of the BTL Cares Scholarship Programhttps://practicaldermatology.com/news/meet-the-winners-of-the-btl-cares-scholarship-program/2461092/BTL and professional basketball player Andre Drummond have selected the five winners of their first-ever scholarship program – the BTL Scholar Draft. The program awarded each of the five students a $15,000 grant towards tuition and college fees. The
- Vial Names Dr. Mark Lebwohl to Scientific Advisory Boardhttps://practicaldermatology.com/news/vial-names-dr-mark-lebwohl-to-scientific-advisory-board/2461091/The Vial Dermatology CRO has added Mark Lebwohl, MD, MPH to the Vial Scientific Advisory Board. Dr. Lebwohl will lend his expertise to the Vial CRO team and leading sponsors working to advance the Dermatology research field.<
- US Senate Passes Dr. Lorna Breen Acthttps://practicaldermatology.com/news/us-senate-passes-lorna-breen-act/2461090/The US Senate has passed the bipartisan Dr. Lorna Breen Health Care Provider Protection Act (H.R. 1667). The bill previously was passed by the US House of Representatives, and now goes to President Biden to be signed into law. Once signed, the Dr. Lorna Breen Health Care
- Adelle Walker Joins DermTech as VP of Consumer Productshttps://practicaldermatology.com/news/adelle-walker-joins-dermtech-as-vp-of-consumer-products/2461088/Adelle Walker is now Vice President of Consumer Products at DermTech. Inc. as the company continues its investment in bringing its precision genomics platform to the skin health and wellness categories. Ms. Walker brings more than 20 years of experience to
- Business News: Taro to Acquire Alchemee From Galdermahttps://practicaldermatology.com/news/business-news-taro-to-acquire-alchemee-from-galderma/2461087/Taro Pharmaceutical Industries Ltd. Is buying Alchemee, formerly The Proactiv Company, from Galderma. The acquisition is subject to customary closing conditions and any necessary regulatory approvals. Financial terms of the transaction have not been disclosed. "We are exc